Cited by 2,149Multiple Sclerosis Research StudiesT-cell and B-cell ImmunologyPsoriasis: Treatment and Pathogenesis

The DOI matches its Crossref record; 362 of the 362 references it cites were found in a registry or an index.

IMMUNOLOGY OF MULTIPLE SCLEROSIS

Sospedra, Mireia, Martin, Roland·2005·Annual Review of Immunology

DOI 10.1146/annurev.immunol.23.021704.115707

Open this paper in CoChat — free account

Abstract

Multiple sclerosis (MS) develops in young adults with a complex predisposing genetic trait and probably requires an inciting environmental insult such as a viral infection to trigger the disease. The activation of CD4+ autoreactive T cells and their differentiation into a Th1 phenotype are a crucial events in the initial steps, and these cells are probably also important players in the long-term evolution of the disease. Damage of the target tissue, the central nervous system, is, however, most likely mediated by other components of the immune system, such as antibodies, complement, CD8+ T cells, and factors produced by innate immune cells. Perturbations in immunomodulatory networks that include Th2 cells, regulatory CD4+ T cells, NK cells, and others may in part be responsible for the relapsing-remitting or chronic progressive nature of the disease. However, an important paradigmatic shift in the study of MS has occurred in the past decade. It is now clear that MS is not just a disease of the immune system, but that factors contributed by the central nervous system are equally important and must be considered in the future.

Integrity signals

Registry

Crossref · 10.1146/annurev.immunol.23.021704.115707

Cites

362 of 362 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
Pasare, C., & Medzhitov, R. M. (2003) · Science · doi:10.1126/science.1078231 · Cited by 2,000
Use of a cDNA microarray to analyse gene expression patterns in human cancer
DeRisi, J. L., Penland, L., Brown, P. O., Bittner, M. L., Meltzer, P. S., Ray, M., Chen, Y.-W., Su, Y. A., & Trent, J. M. (1996) · Nature Genetics · doi:10.1038/ng1296-457 · Cited by 1,952
Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali‐Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J. E., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,918
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher‐Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,858
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M. N., Ravetch, J. V., Steinman, R. M., & Nussenzweig, M. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.769 · Cited by 1,848
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease
Monney, L., Sabatos, C. A., Gaglia, J. L., Ryu, A., Waldner, H., Chernova, T., Manning, S., Greenfield, E. A., Coyle, A. J., Sobel, R. A., et al. (2002) · Nature · doi:10.1038/415536a · Cited by 1,683
Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis
Johnson, K., Brooks, B., Cohen, J. A., Ford, C., Goldstein, J., Lisak, R., Myers, L., Panitch, H., Rose, J., Schiffer, R., et al. (1995) · Neurology · doi:10.1212/wnl.45.7.1268 · Cited by 1,667
Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis
Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E. E., Garren, H., Langer-Gould, A. M., Strober, S., Cannella, B., Allard, J. D., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-500 · Cited by 1,659
Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein
Wucherpfennig, K. W., & Strominger, J. L. (1995) · Cell · doi:10.1016/0092-8674(95)90348-8 · Cited by 1,545
A controlled trial of natalizumab for relapsing multiple sclerosis.
Miller, D. H., Khan, O., Sheremata, W., Blumhardt, L., Rice, G., Libonati, M., Willmer-Hulme, A., Dalton, C., Miszkiel, K., & O'Connor, P. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020696 · Cited by 1,265
Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic mice
Ohashi, P. S., Oehen, S., Buerki, K., Pircher, H., Ohashi, C. T., Odermatt, B., MALISSEN, B., Zinkernagel, R. M., & Hengartner, H. (1991) · Cell · doi:10.1016/0092-8674(91)90164-t · Cited by 1,175
The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease
Youssef, S., Stüve, O., Patarroyo, J. C., Ruiz, P. J., Radosevich, J. L., Hur, E. M., Bravo, M., Mitchell, D. J., Sobel, R. A., Steinman, L., et al. (2002) · Nature · doi:10.1038/nature01158 · Cited by 1,096
TNF neutralization in MS
The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group (1999) · Neurology · doi:10.1212/wnl.53.3.457 · Cited by 1,068
Immunological Aspects Of Demyelinating Diseases
Martinꝉ, R., McFarland, H. F., & McFarlin, D. E. (1992) · Annual Review of Immunology · doi:10.1146/annurev.iy.10.040192.001101 · Cited by 1,021
Self-citation
The T Lymphocyte In Experimental Allergic Encephalomyelitis
Zamvil, S. S., & Steinman, L. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.003051 · Cited by 1,013
Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients
Sørensen, T. L., Tani, M., Jensen, J. S., Pierce, V., Lucchinetti, C. F., Folcik, V. A., Qin, S., Rottman, J., Sellebjerg, F. T., Strieter, R. M., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5150 · Cited by 994
Clonal Expansions of Cd8+ T Cells Dominate the T Cell Infiltrate in Active Multiple Sclerosis Lesions as Shown by Micromanipulation and Single Cell Polymerase Chain Reaction
Babbe, H., Roers, A., Waisman, A., Lassmann, H., Goebels, N., Hohlfeld, R., Friese, M., Schröder, R., Deckert, M., Schmidt, S., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.393 · Cited by 951
Epitope spreading in immune-mediated diseases: implications for immunotherapy
Vanderlugt, C. L., & Miller, S. D. (2002) · Nature reviews. Immunology · doi:10.1038/nri724 · Cited by 947
Amino Acid Homology Between the Encephalitogenic Site of Myelin Basic Protein and Virus: Mechanism for Autoimmunity
Fujinami, R. S., & Oldstone, M. B. A. (1985) · Science · doi:10.1126/science.2414848 · Cited by 947
T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis
Ota, K., Matsui, M., Milford, E. L., Mackin, G. A., Weiner, H. L., & Hafler, D. A. (1990) · Nature · doi:10.1038/346183a0 · Cited by 912
Oral Tolerance: Immunologic Mechanisms and Treatment of Animal and Human Organ-Specific Autoimmune Diseases by Oral Administration of Autoantigens
Weiner, H. L., Friedman, A., Miller, A., Khoury, S. J., AL-Sabbagh, A., dos Santos, L. M. B., Sayegh, M. H., Nussenblatt, R. B., De, T., & Hafler, D. A. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.004113 · Cited by 903
Identification of autoantibodies associated with myelin damage in multiple sclerosis
Genain, C. P., Cannella, B., Hauser, S. L., & Raine, C. S. (1999) · Nature Medicine · doi:10.1038/5532 · Cited by 891
A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells
Miyamoto, K., Miyake, S., & Yamamura, T. (2001) · Nature · doi:10.1038/35097097 · Cited by 879
CCR5 + and CXCR3 + T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions
Balashov, K. E., Rottman, J. B., Weiner, H. L., & Hancock, W. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6873 · Cited by 848
The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease
Chabas, D., Baranzini, S. E., Mitchell, D., Bernard, C. C. A., Rittling, S. R., Denhardt, D. T., Sobel, R. A., Lock, C., Karpuj, M., Pedotti, R., et al. (2001) · Science · doi:10.1126/science.1062960 · Cited by 829
Myelin Oligodendrocyte Glycoprotein–specific T Cell Receptor Transgenic Mice Develop Spontaneous Autoimmune Optic Neuritis
Bettelli, E., Pagany, M., Weiner, H. L., Linington, C., Sobel, R. A., & Kuchroo, V. K. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021603 · Cited by 828
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand
Bielekova, B., Goodwin, B. L., Richert, N. D., Cortese, I. C. M., Kondo, T., Afshar, G., Gran, B., Eaton, J. K., Antel, J. P., Frank, J. A., et al. (2000) · Nature Medicine · doi:10.1038/80516 · Cited by 823
Self-citation
Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide.
Merrill, J. E., Ignarro, L. J., Sherman, M. P., Melinek, J., & Lane, T. E. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.4.2132 · Cited by 782
The adhesion molecule and cytokine profile of multiple sclerosis lesions
Cannella, B., & Raine, C. S. (1995) · Annals of Neurology · doi:10.1002/ana.410370404 · Cited by 759
Treatment of multiple sclerosis with gamma interferon
PANITCH, H. S., Hirsch, R. L., Schindler, J. D., & Johnson, K. P. (1987) · Neurology · doi:10.1212/wnl.37.7.1097 · Cited by 752
Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of anti-self (virus) immune response
Oldstone, M. B. A., Nerenberg, M. I., Southern, P. J., Price, J. A., & Lewicki, H. A. (1991) · Cell · doi:10.1016/0092-8674(91)90165-u · Cited by 751
Glutamate excitotoxicity in a model of multiple sclerosis
Pitt, D., Werner, P., & Raine, C. S. (2000) · Nature Medicine · doi:10.1038/71555 · Cited by 744
THE INFLUENCE OF THE PROINFLAMMATORY CYTOKINE, OSTEOPONTIN, ON AUTOIMMUNE DEMYELINATING DISEASE
Chabas, D., Baranzini, S. E., Mitchell, D. J., Bernard, C. C. A., Rittling, S. R., Denhardt, D. T., Sobel, R. A., Lock, C., Karpuj, M. V., Pedotti, R., et al. (2002) · International Conference on Osteopontin and SIBLING Proteins · doi:10.1100/tsw.2002.326 · Cited by 729
Stimulation of Human γδ T Cells by Nonpeptidic Mycobacterial Ligands
Constant, P., Davodeau, F., Peyrat, M., Poquet, Y., Puzo, G., Bonneville, M., & Fournié, J. (1994) · Science · doi:10.1126/science.8146660 · Cited by 716
Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein.
Linington, C., Bradl, M., Lassmann, H., Brunner, C., & Vass, K. (1988) · PubMed Central · Cited by 711
Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity
Goverman, J. M., Woods, A., Larson, L., Weiner, L. P., Hood, L., & Zaller, D. M. (1993) · Cell · doi:10.1016/0092-8674(93)90074-z · Cited by 684
Diabetes induced by Coxsackie virus: Initiation by bystander damage and not molecular mimicry
Horwitz, M. S., Bradley, L. M., Harbertson, J., Krahl, T., Lee, J., & Sarvennick, N. (1998) · Nature Medicine · doi:10.1038/nm0798-781 · Cited by 667
A Pathogenic Role for Myelin-Specific Cd8+ T Cells in a Model for Multiple Sclerosis
Huseby, E. S., Liggitt, D., Brabb, T., Schnabel, B., Öhlén, C., & Goverman, J. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.5.669 · Cited by 660
OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS
Rivers, T. M., Sprunt, D. H., & Berry, G. P. (1933) · Journal of Experimental Medicine · doi:10.1084/jem.58.1.39 · Cited by 643
Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis after a First Demyelinating Event
Berger, T., Rubner, P., Schautzer, F., Egg, R., Ulmer, H., Mayringer, I., Dilitz, E., Deisenhammer, F., & Reindl, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022328 · Cited by 617
Plaque-associated expression of human herpesvirus 6 in multiple sclerosis.
Challoner, P. B., Smith, K., Parker, J. D. J., MacLeod, D. L., Coulter, S. N., Rose, T., Schultz, E. R., Bennett, J. L., Garber, R. L., & Chang, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7440 · Cited by 617
A genetic basis for familial aggregation in multiple sclerosis
Ebers, G. C., Sadovnick, A. D., & RISCH, N. J. (1995) · Nature · doi:10.1038/377150a0 · Cited by 608
A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H‐2b mice: Fine specificity and T cell receptor Vβ expression of encephalitogenic T cells
Mendel, I., de Rosbo, N. K., & Ben‐Nun, A. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250723 · Cited by 605
CLINICAL VIRAL INFECTIONS AND MULTIPLE SCLEROSIS
SIBLEY, W. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92801-6 · Cited by 595
A functional and structural basis for TCR cross-reactivity in multiple sclerosis
Lang, H., Jacobsen, H. J., Ikemizu, S., Andersson, C., Harlos, K., Madsen, L. S., Hjorth, P., Søndergaard, L., Svejgaard, A., Wucherpfennig, K. W., et al. (2002) · Nature Immunology · doi:10.1038/ni835 · Cited by 592
Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes.
Pettinelli, C. B., & McFarlin, D. E. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.127.4.1420 · Cited by 583
Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains
Bö, L., Dawson, T. M., Wesselingh, S. L., Möurk, S., Choi, S. J., Kong, P. A., Hanley, D. F., & Trapp, B. D. (1994) · Annals of Neurology · doi:10.1002/ana.410360515 · Cited by 567
Autoimmunity to Myelin Oligodendrocyte Glycoprotein in Rats Mimics the Spectrum of Multiple Sclerosis Pathology
Storch, M., Stefferl, A., Brehm, U., Weissert, R., Wallström, E., Kerschensteiner, M., Olsson, T., Linington, C., & Lassmann, H. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00194.x · Cited by 566
Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading
Miller, S. D., Vanderlugt, C. L., Begolka, W. S., Pao, W., Yauch, R. L., Neville, K. L., Katz-Levy, Y., Carrizosa, A., & Kim, B. S. (1997) · Nature Medicine · doi:10.1038/nm1097-1133 · Cited by 565
Genetics of multiple sclerosis
Dyment, D. A., Ebers, G. C., & Dessa Sadovnick, A. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00663-x · Cited by 563
Delineating the Genetic Basis of Systemic Lupus Erythematosus
Wakeland, E. K., Liu, K., Graham, R., & Behrens, T. W. (2001) · Immunity · doi:10.1016/s1074-7613(01)00201-1 · Cited by 560
An Interleukin (IL)-10/IL-12 Immunoregulatory Circuit Controls Susceptibility to Autoimmune Disease
Segal, B., Dwyer, B. K., & Shevach, E. (1998) · Journal of Experimental Medicine · doi:10.1084/jem.187.4.537 · Cited by 534
High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice
Lafaille, J. J., Nagashima, K., Katsuki, M., & Tonegawa, S. (1994) · Cell · doi:10.1016/0092-8674(94)90419-7 · Cited by 532
The epidemiology of multiple sclerosis
Goodin, D. S. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802973-2.00011-2 · Cited by 517
Cc Chemokine Receptor 2 Is Critical for Induction of Experimental Autoimmune Encephalomyelitis
Fife, B. T., Huffnagle, G. B., Kuziel, W. A., & Karpus, W. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.6.899 · Cited by 511
Multiple sclerosis: Altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage
Werner, P., Pitt, D., & Raine, C. S. (2001) · Annals of Neurology · doi:10.1002/ana.1077 · Cited by 488
Multiple sclerosis: Re-expression of a developmental pathway that restricts oligodendrocyte maturation
John, G. R., Shankar, S. L., Shafit‐Zagardo, B., Massimi, A. B., Lee, S. C., Raine, C. S., & Brosnan, C. F. (2002) · Nature Medicine · doi:10.1038/nm781 · Cited by 481
Oral simvastatin treatment in relapsing-remitting multiple sclerosis
Vollmer, T. R., Key, L., Durkalski, V., Tyor, W. R., Corboy, J. R., Markovic‐Plese, S., Preiningerova, J. L., Rizzo, M., & Singh, I. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16205-3 · Cited by 471
Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions.
Windhagen, A., Newcombe, J., Dangond, F., Strand, C., Woodroofe, M. N., Cuzner, M. L., & Hafler, D. A. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.6.1985 · Cited by 454
Myelin Antigen-Specific CD8+ T Cells Are Encephalitogenic and Produce Severe Disease in C57BL/6 Mice
Sun, D., Whitaker, J. N., Huang, Z., Liu, D., Coleclough, C., Wekerle, H., & Raine, C. S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7579 · Cited by 444
T Cells Responsive to Myelin Basic Protein in Patients with Multiple Sclerosis
Allegretta, M., Nicklas, J. A., Sriram, S., & Albertini, R. J. (1990) · Science · doi:10.1126/science.1689076 · Cited by 436
Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells
Klein, L., Klugmann, M., Nave, K., Tuohy, V., & Kyewski, B. (2000) · Nature Medicine · doi:10.1038/71540 · Cited by 435
Treatment of multiple sclerosis with the pregnancy hormone estriol
Sicotte, N. L., Liva, S. M., Klutch, R., Pfeiffer, P., Bouvier, S., Odesa, S., Wu, T. C. J., & Voskuhl, R. R. (2002) · Annals of Neurology · doi:10.1002/ana.10301 · Cited by 435
Migratory Activity and Functional Changes of Green Fluorescent Effector Cells before and during Experimental Autoimmune Encephalomyelitis
Flügel, A., Berkowicz, T., Ritter, T., Labeur, M. S., Jenne, D. E., Li, Z., Ellwart, J. W., Willem, M., Lassmann, H., & Wekerle, H. (2001) · Immunity · doi:10.1016/s1074-7613(01)00143-1 · Cited by 431
Myelin Basic Protein–specific T Helper 2 (Th2) Cells Cause Experimental Autoimmune Encephalomyelitis in Immunodeficient Hosts Rather than Protect Them from the Disease
Lafaille, J. J., de Keere, F. V., Hsu, A. L., Baron, J. L., Haas, W., Raine, C. S., & Tonegawa, S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.307 · Cited by 426
Multiple sclerosis: In situ evidence for antibody‐ and complement‐mediated demyelination
Storch, M. K., Piddlesden, S. J., Haltia, M., Iivanainen, M. V., Morgan, P. B., & Lassmann, H. (1998) · Annals of Neurology · doi:10.1002/ana.410430409 · Cited by 422
Multiple Sclerosis
McFarlin, D. E., & McFarland, H. F. (1982) · New England Journal of Medicine · doi:10.1056/nejm198211043071905 · Cited by 420
Interleukin 6 plays a key role in the development of antigen-induced arthritis
Ohshima, S., Saeki, Y., Mima, T., Sasai, M., Nishioka, K., Nomura, S., Kopf, M., Katada, Y., Tanaka, T., Suemura, M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8222 · Cited by 406
The small heat-shock protein αB-crystallin as candidate autoantigen in multiple sclerosis
van Noort, J. M., van Sechel, A. C., Bajramovic, J. J., Ouagmiri, M. E., Polman, C. H., Lassmann, H., & Ravid, R. (1995) · Nature · doi:10.1038/375798a0 · Cited by 402
Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy
Wraith, D. C., Smilek, D. E., Mitchell, D. J., Steinman, L., & McDevitt, H. O. (1989) · Cell · doi:10.1016/0092-8674(89)90287-0 · Cited by 387
Limited heterogeneity of rearranged T-cell receptor Vα transcripts in brains of multiple sclerosis patients
Oksenberg, J. R., Stuart, S. J., Begovich, A. B., Bell, R. B., Erlich, H. A., Steinman, L., & Bernard, C. C. A. (1990) · Nature · doi:10.1038/345344a0 · Cited by 387
Shared Human T Cell Receptor V β Usage to Immunodominant Regions of Myelin Basic Protein
Wucherpfennig, K. W., Ota, K., Endo, N., Seidman, J. G., Rosenzweig, A., Weiner, H. L., & Hafler, D. A. (1990) · Science · doi:10.1126/science.1693015 · Cited by 383
Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma.
Olsson, T. P., Zhi, W. W., Höjeberg, B., Kostulas, V., Jiang, Y., Anderson, G., Ekre, H. P., & Link, H. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114800 · Cited by 370
A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease.
Schluesener, H. J., Sobel, R. A., Linington, C., & Weiner, H. L. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.12.4016 · Cited by 370
IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells
Zhang, X. (2004) · International Immunology · doi:10.1093/intimm/dxh029 · Cited by 365
Regulation of Experimental Autoimmune Encephalomyelitis by Natural Killer (NK) Cells
Zhang, B., Yamamura, T., Kondo, T., Fujiwara, M., & Tabira, T. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.10.1677 · Cited by 364
Multiple sclerosis: Brain-infiltrating CD8 + T cells persist as clonal expansions in the cerebrospinal fluid and blood
Skulina, C., Schmidt, S., Dornmair, K., Babbe, H., Roers, A., Rajewsky, K., Wekerle, H., Hohlfeld, R., & Goebels, N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308689100 · Cited by 351
Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis
Runmarker, B., & Andersen, O. (1995) · Brain · doi:10.1093/brain/118.1.253 · Cited by 351
Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study
Reindl, M., Linington, C., Brehm, U., Egg, R., Dilitz, E., Deisenhammer, F., Poewe, W. H., & Berger, T. (1999) · Brain · doi:10.1093/brain/122.11.2047 · Cited by 347
Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals.
Martin, R., Jaraquemada, D., Flerlage, M., Richert, J., Whitaker, J., Long, E. O., McFarlin, D. E., & McFarland, H. F. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.2.540 · Cited by 342
Self-citation
Multiple sclerosis
Hafler, D. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21357 · Cited by 342
A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor
Madsen, L. S., Andersson, E. C., Jansson, L., Krogsgaard, M., Andersen, C. B., Engberg, J., Strominger, J. L., Svejgaard, A., Hjorth, J. P., Holmdahl, R., et al. (1999) · Nature Genetics · doi:10.1038/15525 · Cited by 335
Myelin basic protein‐specific T lymphocyte lines from MS patients and healthy individuals
Pette, M., Fujita, K., Kitze, B., Whitaker, J. N., Albert, E., Kappos, L., & Wekerle, H. (1990) · Neurology · doi:10.1212/wnl.40.11.1770 · Cited by 333
Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis.
Qin, Y., Duquette, P., Zhang, Y., Talbot, P. J., Poole, R., & Antel, J. P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3568 · Cited by 323
Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones.
Wucherpfennig, K. W., Sette, A., Southwood, S., Oseroff, C., Matsui, M., Strominger, J. L., & Hafler, D. A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.1.279 · Cited by 322
Increased interleukin 12 production in progressive multiple sclerosis: Induction by activated CD4 + T cells via CD40 ligand
Balashov, K. E., Smith, D. R., Khoury, S. J., Hafler, D. A., & Weiner, H. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.599 · Cited by 316
T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis
Sun, J., Link, H., Olsson, T. P., Xiao, B. G., Andersson, G., Ekre, H. P., Linington, C., & Diener, P. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.5.1490 · Cited by 315
Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β
Bielekova, B., Richert, N. D., Howard, T., Blevins, G., Markovic‐Plese, S., McCartin, J., Wuerfel, J. T., Ohayon, J. M., Waldmann, T. A., McFarland, H. F., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402653101 · Cited by 314
Self-citation
Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.
Genain, C. P., Nguyen, M. H., Letvin, N. L., Pearl, R., Davis, R. L., Adelman, M. H., Lees, M. B., Linington, C., & Hauser, S. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118368 · Cited by 314
Identification of High Potency Microbial and Self Ligands for a Human Autoreactive Class II–restricted T Cell Clone
Hemmer, B., Fleckenstein, B. T., Vergelli, M., Jung, G., McFarland, H. F., Martinꝉ, R., & Wiesmüller, K.-H. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1651 · Cited by 313
Self-citation
Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors.
Pette, M., Fujita, K., Wilkinson, D., Altmann, D. M., Trowsdale, J., Giegerich, G., Hinkkanen, A., Epplen, J. T., Kappos, L., & Wekerle, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.20.7968 · Cited by 307
Association between clinical disease activity and Epstein–Barr virus reactivation in MS
Wandinger, K.-P., Jabs, W. J., Siekhaus, A., Bubel, S., Trillenberg, P., Wagner, H. J., Wessel, K., Kirchner, H., & Hennig, H. (2000) · Neurology · doi:10.1212/wnl.55.2.178 · Cited by 302
Development of biomarkers in multiple sclerosis
Bielekova, B., & Martinꝉ, R. (2004) · Brain · doi:10.1093/brain/awh176 · Cited by 299
Self-citation
Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease
Fogdell‐Hahn, A., Ligers, A., Grønning, M., Hillert, J. A., & Olerup, O. (2000) · Tissue Antigens · doi:10.1034/j.1399-0039.2000.550205.x · Cited by 295
B Cell Repertoire Diversity and Clonal Expansion in Multiple Sclerosis Brain Lesions
Baranzini, S. E., Jeong, M. C., Butunoi, C., Murray, R. S., Bernard, C. C. A., & Oksenberg, J. R. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.5133 · Cited by 294
HLA-DR2 Dose Effect on Susceptibility to Multiple Sclerosis and Influence on Disease Course
Barcellos, L. F., Oksenberg, J. R., Begovich, A. B., Martin, E. R., Schmidt, S., Vittinghoff, E., Goodin, D. S., Pelletier, D., Lincoln, R., Bucher, P., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/367781 · Cited by 293
Animal models
Wekerle, H., Kojima, K., Lannes-Vieira, J., Lassmann, H., & Linington, C. (1994) · Annals of Neurology · doi:10.1002/ana.410360714 · Cited by 291
Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases
Pender, M. P. (2003) · Trends in Immunology · doi:10.1016/j.it.2003.09.005 · Cited by 284
A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis.
Martinꝉ, R., Howell, M. D., Jaraquemada, D., Flerlage, M., Richert, J. R., Brostoff, S. W., Long, E. O., McFarlin, D. E., & McFarland, H. F. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.173.1.19 · Cited by 283
Self-citation
Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group
Haines, J. L. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.8.1229 · Cited by 281
T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis
Iglesias, A., Bauer, J., Litzenburger, T., Schubart, A., & Linington, C. (2001) · Glia · doi:10.1002/glia.1111 · Cited by 280
Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy
Ziemssen, T. (2002) · Brain · doi:10.1093/brain/awf252 · Cited by 268
Circulating Vα24+ Vβ11+ NKT Cell Numbers Are Decreased in a Wide Variety of Diseases That Are Characterized by Autoreactive Tissue Damage
van der Vliet, H. J., Blomberg, B. M. E. V., Nishi, N., Reijm, M., Voskuyl, A. E., Bodegraven, A. A. V., Polman, C. H., Rustemeyer, T., Lips, P. T. A. M., van den Eertwegh, A. J. M., et al. (2001) · Clinical Immunology · doi:10.1006/clim.2001.5060 · Cited by 267
Acute multiple sclerosis (marburg type) is associated with developmentally immature myelin basic protein
Wood, D. D., Moscarello, M. A., Bilbao, J. M., & O'Connors, P. (1996) · Annals of Neurology · doi:10.1002/ana.410400106 · Cited by 266
Isolation of myelin basic protein-reactive T-cell lines from normal human blood
Burns, J. B., Rosenzweig, A., Zweiman, B., & Lisak, R. P. (1983) · Cellular Immunology · doi:10.1016/0008-8749(83)90250-2 · Cited by 266
Experimental autoimmune encephalomyelitis (EAE) mediated by T cell lines: process of selection of lines and characterization of the cells.
Ben‐Nun, A., & Cohen, I. R. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.129.1.303 · Cited by 260
Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells.
Lovett‐Racke, A. E., Trotter, J. L., Lauber, J., Perrin, P. J., June, C. H., & Racke, M. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1528 · Cited by 260
Differential Expression of NK T Cell Vα24JαQ Invariant TCR Chain in the Lesions of Multiple Sclerosis and Chronic Inflammatory Demyelinating Polyneuropathy
Illés, Z., Kondo, T., Newcombe, J., Oka, N., Tabira, T., & Yamamura, T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4375 · Cited by 258
Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls
Sun, J., Olsson, T. P., Wang, W., Xiao, B., Kostulas, V., Fredrikson, S., Ekre, H.-P. T., & Link, H. (1991) · European Journal of Immunology · doi:10.1002/eji.1830210620 · Cited by 257
B Lymphocytes Producing Demyelinating Autoantibodies: Development and Function in Gene-targeted Transgenic Mice
Litzenburger, T., Fässler, R., Bauer, J., Lassmann, H., Linington, C., Wekerle, H., & Iglesias, A. H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.1.169 · Cited by 257
Intravenous immunoglobulin treatment in multiple sclerosis Effect on relapses
Achiron, A., Gabbay, U., Gilad, R., Hassin‐Baer, S., Barak, Y., Gornish, M., Elizur, A., Goldhammer, Y., & Sarova-Pinhas, I. (1998) · Neurology · doi:10.1212/wnl.50.2.398 · Cited by 256
Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients
Jacobsen, M., Cepok, S., Quak, E., Happel, M., Gaber, R., Ziegler, A., Schock, S., Oertel, W. H., Sommer, N., & Hemmer, B. (2002) · Brain · doi:10.1093/brain/awf059 · Cited by 253
Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen
Brocke, S., Gaur, A., Piercy, C., Gautam, A. M., Gijbels, K., Fathman, C. G., & Steinman, L. (1993) · Nature · doi:10.1038/365642a0 · Cited by 252
B cells and antibodies in CNS demyelinating disease
Cross, A. H., Trotter, J. L., & Lyons, J. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00409-4 · Cited by 252
High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay
Crawford, M. P., Yan, S. X., Ortega, S. B., Mehta, R. S., Hewitt, R. E., Price, D. A., Šťastný, P., Douek, D. C., Koup, R. A., Racke, M. K., et al. (2004) · Blood · doi:10.1182/blood-2003-11-4025 · Cited by 250
Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement
Scolding, N. J., Morgan, B. P., Houston, W. A. J., Linington, C., Campbell, A. K., & Compston, D. A. S. (1989) · Nature · doi:10.1038/339620a0 · Cited by 245
CD4+CD28– costimulation-independent T cells in multiple sclerosis
Markovic‐Plese, S., Cortese, I. C. M., Wandinger, K., McFarland, H. F., & Martinꝉ, R. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12516 · Cited by 243
Self-citation
CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis
Trebst, C., Lykke Sørensen, T., Kivisäkk, P., Cathcart, M. K., Hesselgesser, J., Horuk, R., Sellebjerg, F., Lassmann, H., & Ransohoff, R. M. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63017-9 · Cited by 242
Expansion and Functional Relevance of High-Avidity Myelin-Specific CD4+ T Cells in Multiple Sclerosis
Bielekova, B., Sung, M., Kadom, N., Simon, R. M., McFarland, H. F., & Martinꝉ, R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3893 · Cited by 241
Self-citation
Cross‐reactivity with myelin basic protein and human herpesvirus‐6 in multiple sclerosis
Tejada-Simon, M. V., Zang, Y. C. Q., Hong, J., Rivera, V. M., & Zhang, J. Z. (2003) · Annals of Neurology · doi:10.1002/ana.10425 · Cited by 238
Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis
Robinson, W. H., da Fontoura, P. P., Lee, B. J., de Vegvar, H. E. N., Tom, J. A., Pedotti, R., DiGennaro, C., Mitchell, D. J., Fong, D., Ho, P. P.-K., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt859 · Cited by 236
Self-citation
Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis.
Kotzin, B. L., Karuturi, S., Chou, Y. K., Lafferty, J., Forrester, J. M., Better, M., Nedwin, G. E., Offner, H., & Vandenbark, A. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.9161 · Cited by 235
Molecular Changes in Normal Appearing White Matter in Multiple Sclerosis are Characteristic of Neuroprotective Mechanisms Against Hypoxic Insult
Graumann, U., Reynolds, R., Steck, A. J., & Schaeren‐Wiemers, N. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00485.x · Cited by 232
The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination
Karnezis, T., Mandemakers, W. J., McQualter, J. L., Zheng, B., Ho, P. P.-K., Jordan, K. A., Murray, B., Barres, B. A., Tessier‐Lavigne, M., & Bernard, C. C. A. (2004) · Nature Neuroscience · doi:10.1038/nn1261 · Cited by 230
High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis
Nash, R. A., Bowen, J. D., McSweeney, P. A., Pavletic, S. Z., Maravilla, K. R., Park, M.-S., Storek, J., Sullivan, K. M., Al-Omaishi, J., Corboy, J. R., et al. (2003) · Blood · doi:10.1182/blood-2002-12-3908 · Cited by 221
T Cell Ig- and Mucin-Domain-Containing Molecule-3 (TIM-3) and TIM-1 Molecules Are Differentially Expressed on Human Th1 and Th2 Cells and in Cerebrospinal Fluid-Derived Mononuclear Cells in Multiple Sclerosis
Khademi, M., Illés, Z., Gielen, A. W., Marta, M., Takazawa, N., Baecher‐Allan, C., Brundin, L., Hannerz, J., Martin, C., Harris, R. A., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.7169 · Cited by 217
Expression of the β-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue
Simpson, J. E., Rezaie, P., Newcombe, J., Cuzner, M. L., Male, D. K., & Woodroofe, M. N. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00274-5 · Cited by 214
Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease
Bomprezzi, R., Ringnér, M., Kim, S., Bittner, M. L., Khan, J. I., Chen, Y., ELKAHLOUN, A. G., Yu, A. Y., Bielekova, B., Meltzer, P. S., et al. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg221 · Cited by 214
Self-citation
Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation–based conditioning regimen to prevent disease progression in patients with high disability scores
Burt, R. K., Cohen, B. A., Russell, E. J., Spero, K., Joshi, A., Oyama, Y., Karpus, W. J., Luo, K., Jovanovic, B. D., Traynor, A. E., et al. (2003) · Blood · doi:10.1182/blood-2003-03-0877 · Cited by 210
CD4+CD28– costimulation-independent T cells in multiple sclerosis
Markovic‐Plese, S., Cortese, I. C. M., Wandinger, K., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112516 · Cited by 210
Cytokine-regulated proteases in autoimmune diseases
Opdenakker, G., & Damme, J. V. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90151-1 · Cited by 208
TNF-related apoptosis inducing ligand (TRAIL) as a potential response marker for interferon-beta treatment in multiple sclerosis
Wandinger, K., Lünemann, J. D., Wengert, O., Bellmann–Strobl, J., Aktaş, O., Weber, A., Grundström, E., Ehrlich, S., Wernecke, K. ‐., Volk, H., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13641-0 · Cited by 208
Immunoglobulins promote remyelination in the central nervous system
Rodriguez, M., & Lennon, V. A. (1990) · Annals of Neurology · doi:10.1002/ana.410270104 · Cited by 207
Demyeliating neuropathy and monoclonal IgM antibody to myelin‐associated glycoprotein
Steck, A. J., Murray, N., Meier, C., Page, N., & Perruisseau, G. (1983) · Neurology · doi:10.1212/wnl.33.1.19 · Cited by 206
Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
Valli, A., Sette, A., Kappos, L., Oseroff, C., Sidney, J., Miescher, G., Hochberger, M., Albert, E. D., & Adorini, L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116242 · Cited by 201
Roles of TNF-Related Apoptosis-Inducing Ligand in Experimental Autoimmune Encephalomyelitis
Hilliard, B. A., Wilmen, A., Seidel, C., Liu, T.-S. T., Göke, R., & Chen, Y. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.1314 · Cited by 198
The Membrane Attack Complex of Complement Causes Severe Demyelination Associated with Acute Axonal Injury
Mead, R. J., Singhrao, S. K., Neal, J., Lassmann, H., & Morgan, B. P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.1.458 · Cited by 198
Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease
Waldner, H., Collins, M. A., & Kuchroo, V. K. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19388 · Cited by 198
Multiple sclerosis (second of two parts).
Mcfarlin, D., & McFarland, H. (1982) · New England Journal of Medicine · doi:10.1056/nejm198211113072005 · Cited by 198
Autoaggressive T lymphocyte lines recognizing the encephalitogenic region of myelin basic protein: in vitro selection from unprimed rat T lymphocyte populations.
Schluesener, H. J., & Wekerle, H. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.5.3128 · Cited by 197
Visualization of Myelin Basic Protein (Mbp) T Cell Epitopes in Multiple Sclerosis Lesions Using a Monoclonal Antibody Specific for the Human Histocompatibility Leukocyte Antigen (Hla)-Dr2–Mbp 85–99 Complex
Krogsgaard, M., Wucherpfennig, K. W., Cannella, B., Hansen, B. E., Svejgaard, A., Pyrdol, J. W., Ditzel, H. J., Raine, C. S., Engberg, J., & Fugger, L. H. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.8.1395 · Cited by 195
Expansion of Autoreactive T Cells in Multiple Sclerosis Is Independent of Exogenous B7 Costimulation
Scholz, C. W., Patton, K. T., Anderson, D. E., Freeman, G. J., & Hafler, D. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1532 · Cited by 194
Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes
Mitrovic, B., Ignarro, L. J., Vinters, H. V., Akers, M.-A., Schmid, I., Uíttenbogaart, C. H., & Merrill, J. E. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00491-m · Cited by 193
Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes.
Wucherpfennig, K. W., Catz, I., Hausmann, S., Strominger, J. L., Steinman, L., & Warren, K. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119622 · Cited by 190
Restricted T-cell receptor V beta gene usage by myelin basic protein-specific T-cell clones in multiple sclerosis: predominant genes vary in individuals.
Ben‐Nun, A., Liblau, R., Cohen, L., Lehmann, D., Tournier‐Lasserve, E., Rosenzweig, A., Zhang, J. W., Raus, J. C. M., & Bach, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2466 · Cited by 188
Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia.
Kojima, K., Berger, T., Lassmann, H., Hinze‐Selch, D., Zhang, Y., Gehrmann, J., Reske, K., Wekerle, H., & Linington, C. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.3.817 · Cited by 188
Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system.
Berger, T., Weerth, S., Kojima, K., Linington, C., Wekerle, H., & Lassmann, H. (1997) · PubMed · Cited by 185
A STUDY OF THE CRYSTALLINE ALBUMIN, GAMMA GLOBULIN AND TOTAL PROTEIN IN THE CEREBROSPINAL FLUID OF ONE HUNDRED CASES OF MULTIPLE SCLEROSIS AND IN OTHER DISEASES
Kabat, E. A., Freedman, D. A., Murray, J. P., & Knaub, V. (1950) · The American Journal of the Medical Sciences · doi:10.1097/00000441-195001000-00009 · Cited by 185
Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS
Giunti, D., Borsellino, G., Benelli, R., Marchese, M., Capello, E., Valle, M. T., Pedemonte, E., Noonan, D. M., Albini, A., Bernardi, G., et al. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.1202598 · Cited by 180
Vitamin D: a natural inhibitor of multiple sclerosis
Hayes, C. E. (2000) · Proceedings of The Nutrition Society · doi:10.1017/s0029665100000768 · Cited by 179
Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides.
Vogt, A. B., Kropshofer, H., Kalbacher, H., Kalbus, M., Rammensee, H., Coligan, J. E., & Martinꝉ, R. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.4.1665 · Cited by 177
Self-citation
Complex immunomodulatory effects of interferon‐β in multiple sclerosis include the upregulation of T helper 1‐associated marker genes
Wandinger, K., Stürzebecher, C.-S., Bielekova, B., Detore, G. R., Rosenwald, A., Staudt, L. M., McFarland, H. F., & Martinꝉ, R. (2001) · Annals of Neurology · doi:10.1002/ana.1096 · Cited by 176
Self-citation
Restricted use of VH4 Germline segments in an acute multiple sclerosis brain
Owens, G. P., Kannus, H., Burgoon, M. P., Smith‐Jensen, T., Devlin, M. E., & Gilden, D. H. (1998) · Annals of Neurology · doi:10.1002/ana.410430214 · Cited by 172
IMMUNOGLOBULIN-CONTAINING CELLS IN MULTIPLE-SCLEROSIS PLAQUES
Esiri, M. M. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91603-8 · Cited by 171
Immunomodulatory action of intravenous immunoglobulin
Sewell, W. A. C., & Jolles, S. R. A. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01545.x · Cited by 171
Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: Reactivity to the extracellular domain of MOG is directed against three main regions
de Rosbo, N. K., Hoffman, M. A., Mendel, I., Yust, I., Kaye, J., Bakimer, R., Flechter, S., Abramsky, O., Milo, R., Karni, A., et al. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271144 · Cited by 169
Expression profiling identifies responder and non‐responder phenotypes to interferon‐β in multiple sclerosis
Stürzebecher, S., Wandinger, K., Rosenwald, A., Sathyamoorthy, M., Tzou, A., Mattar, P. A., Frank, J. A., Staudt, L. M., Martinꝉ, R., & McFarland, H. F. (2003) · Brain · doi:10.1093/brain/awg147 · Cited by 168
Self-citation
Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS
Mancardi, G., Saccardi, R., Filippi, M., Gualandi, F., Murialdo, A., Inglese, M., Marrosu, M. G., Meucci, G., Massacesi, L., Lugaresi, A., et al. (2001) · Neurology · doi:10.1212/wnl.57.1.62 · Cited by 168
Treatment of multiple sclerosis with T–cell receptor peptides: Results of a double–blind pilot trial
Vandenbark, A. A., Chou, Y. K., Whitham, R. H., Mass, M. K., Buenafe, A. C., Liefeld, D., Kavanagh, D. G., Cooper, S., Hashim, G. A., Offner, H., et al. (1996) · Nature Medicine · doi:10.1038/nm1096-1109 · Cited by 168
Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis.
Walsh, M. J., & Tourtellotte, W. W. (1986) · The Journal of Experimental Medicine · doi:10.1084/jem.163.1.41 · Cited by 168
Macrophage phagocytosis of myelin in vitro determined by flow cytometry: phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-α and nitric oxide
van der Laan, L. J. W., Ruuls, S. R., Weber, K. S., Lodder, I. J., Döpp, E. A., & Dijkstra, C. D. (1996) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00110-5 · Cited by 166
Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor.
Benczur, M., Petrányl, G. G., Pálffy, G., Varga, M., Tálas, M., Kotsy, B., Földeş, I., & Hollán, S. R. (1980) · PubMed Central · Cited by 165
Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides
Evavold, B. D., Sloan‐Lancaster, J., Hsu, B. L., & Allen, P. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.8.3131 · Cited by 165
MHC Class I-Restricted Lysis of Human Oligodendrocytes by Myelin Basic Protein Peptide-Specific CD8 T Lymphocytes
Jurewicz, A., Biddison, W. E., & Antel, J. P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.6.3056 · Cited by 164
Genetic models for CNS inflammation
Owens, T., Wekerle, H., & Antel, J. P. (2001) · Nature Medicine · doi:10.1038/84603 · Cited by 164
Subpopulations of human peripheral T gamma delta lymphocytes
Triebel, F., & Hercend, T. (1989) · Immunology Today · doi:10.1016/0167-5699(89)90321-6 · Cited by 164
Increased transforming growth factor‐β, interleukin‐4, and interferon‐γ in multiple sclerosis
Link, J., Söderström, M. B., Olsson, T. P., Höjeberg, B., Ljungdahl, Å., & Link, H. (1994) · Annals of Neurology · doi:10.1002/ana.410360309 · Cited by 162
Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis.
Correale, J. D., Gilmore, W., McMillan, M., Li, S., McCarthy, K. A., Le, T. P., & Weiner, L. P. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.6.2959 · Cited by 161
Interleukin‐6 functions in autoimmune encephalomyelitis: a study in gene‐targeted mice
Mendel, I., Katz, A., Kozak, N., Ben‐Nun, A., & Revel, M. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199805)28:05 · Cited by 161
Interferon γ, interleukin 4 and transforming growth factor β in experimental autoimmune encephalomyelitis in lewis rats: Dynamics of cellular mrna expression in the central nervous system and lymphoid cells
Issazadeh‐Navikas, S., Mustafa, M., Ljungdahl, Å., Höjeberg, B., Dagerlind, Å., Elde, R., & Olsson, T. P. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490400503 · Cited by 158
Transcriptional Analysis of Multiple Sclerosis Brain Lesions Reveals a Complex Pattern of Cytokine Expression
Baranzini, S. E., Elfstrom, C., Chang, S.-Y. P., Butunoi, C., Murray, R. S., Higuchi, R., & Oksenberg, J. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6576 · Cited by 157
Autoreactive CD8+ T-cell responses to human myelin protein-derived peptides.
Tsuchida, T., Parker, K. C., Turner, R. V., McFarland, H. F., Coligan, J. E., & Biddison, W. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10859 · Cited by 156
Fulminant spontaneous autoimmunity of the central nervous system in mice transgenic for the myelin proteolipid protein-specific T cell receptor
Waldner, H., Whitters, M. J., Sobel, R. A., Collins, M. A., & Kuchroo, V. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3412 · Cited by 156
Cutting Edge: Predictable TCR Antigen Recognition Based on Peptide Scans Leads to the Identification of Agonist Ligands with No Sequence Homology
Hemmer, B., Vergelli, M., Gran, B., Ling, N., Conlon, P. J., Pinilla, C., Houghten, R. A., McFarland, H. F., & Martinꝉ, R. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.8.3631 · Cited by 156
Self-citation
Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein
Lindert, R.-B., Haase, C. G., Brehm, U., Linington, C., Wekerle, H., & Hohlfeld, R. (1999) · Brain · doi:10.1093/brain/122.11.2089 · Cited by 154
Blood transcriptional signatures of multiple sclerosis: Unique gene expression of disease activity
Achiron, A., Gurevich, M., Friedman, N., Kaminski, N., & Mandel, M. (2004) · Annals of Neurology · doi:10.1002/ana.20008 · Cited by 153
Microarray analysis of gene expression in multiple sclerosis and EAE identifies 5-lipoxygenase as a component of inflammatory lesions
Whitney, L. W., Ludwin, S. K., McFarland, H. F., & Biddison, W. E. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00438-6 · Cited by 152
Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology.
Hemmer, B., Vergelli, M., Gran, B., et al. (1998) · PubMed · Cited by 151
Leishmania donovani promastigotes evade the activation of mitogen-activated protein kinases p38, c-Jun N-terminal kinase, and extracellular signal-regulated kinase-1/2 during infection of naive macrophages
Privé, C., & Descoteaux, A. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(2000)30:8 · Cited by 148
Quantitative and qualitative changes in gene expression patterns characterize the activity of plaques in multiple sclerosis.
Tajouri, L., Mellick, A., Ashton, K., Tannenberg, A., Nagra, R., Tourtellotte, W., & Griffiths, L. (2003) · Brain Research. Molecular Brain Research · doi:10.1016/j.molbrainres.2003.09.008 · Cited by 147
Isoelectric focusing of IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis brains
Mattson, D. H., Roos, R. P., & Arnason, B. G. W. (1980) · Nature · doi:10.1038/287335a0 · Cited by 145
The virology of demyelinating diseases
Johnson, R. T. (1994) · Annals of Neurology · doi:10.1002/ana.410360715 · Cited by 145
Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones.
Meinl, E., Weber, F., Drexler, K., Morelle, C., Ott, M., Saruhan‐Direskeneli, G., Goebels, N., Ertl-Wagner, B. B., Jechart, G., & Giegerich, G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116879 · Cited by 145
Increased CD8+ Cytotoxic T Cell Responses to Myelin Basic Protein in Multiple Sclerosis
Zang, Y. C. Q., Li, S., Rivera, V. M., Hong, J., Robinson, R. R., Breitbach, W. T., Killian, J. M., & Zhang, J. Z. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.5120 · Cited by 144
T-cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation: implications for CNS trafficking
Kivisäkk, P., Trebst, C., Liu, Z., Tucky, B. H., Sørensen, T. L., Rudick, R. A., Mack, M., & Ransohoff, R. M. (2002) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2002.01947.x · Cited by 142
Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory T cells
Manzotti, C. N., Tipping, H., Perry, L., Mead, K. I., Blair, P. J., Zheng, Y., & Sansom, D. M. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(2002010)32:10 · Cited by 142
Self-citation
Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides.
Kennedy, M., Tan, L., Canto, M. C. D., Tuohy, V. K., Lu, Z. J., Trotter, J. L., & Miller, S. D. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.3.909 · Cited by 140
Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis
Sadatipour, B. T., Greer, J. M., & Pender, M. P. (1998) · Annals of Neurology · doi:10.1002/ana.410440621 · Cited by 139
Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells.
Saoudi, A., Simmonds, S. J., Huitinga, I., & Mason, D. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.2.335 · Cited by 138
Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis.
Bánki, K., Colombo, E., SIa, F., Halladay, D. L., Mattson, D. H., Tatum, A. H., Massa, P. T., Phillips, P. E., & Perl, A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.5.1649 · Cited by 138
Activation of APCs Through CD40 or Toll-Like Receptor 9 Overcomes Tolerance and Precipitates Autoimmune Disease
Ichikawa, H. T., Williams, L. P., & Segal, B. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2781 · Cited by 137
Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis
Utz, U., Biddison, W. E., McFarland, H. F., McFarlin, D. E., Flerlage, M., & Martinꝉ, R. (1993) · Nature · doi:10.1038/364243a0 · Cited by 130
Self-citation
Multiple sclerosis associated with Chlamydia pneumoniae infection of the CNS
Sriram, S., Mitchell, W. M., & Stratton, C. W. (1998) · Neurology · doi:10.1212/wnl.50.2.571 · Cited by 129
The pathology of primary progressive multiple sclerosis
Brück, W., Lucchinetti, C., & Lassmann, H. (2002) · Multiple Sclerosis · doi:10.1191/1352458502ms785rr · Cited by 129
Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis
Sørensen, T. L., Sellebjerg, F. T., Jensen, C. V., Strieter, R. M., & Ransohoff, R. M. (2001) · European Journal of Neurology · doi:10.1046/j.1468-1331.2001.00327.x · Cited by 127
Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: imbalance of Th1/Th2-associated chemokine signaling
Misu, T., Onodera, H., Fujihara, K., Matsushima, K., Yoshie, O., Okita, N., Takase, S., & Itoyama, Y. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00456-2 · Cited by 125
CD1-restricted T-cell responses and microbial infection
Park, S.-H., & Bendelac, A. S. (2000) · Nature · doi:10.1038/35021233 · Cited by 124

Research works printed but not linked: 12

McFarland HF, 1999, Am. J. Neuroradiol., 20, 1777
10.1172/JCI200421357 · DOI
Charcot J, 1868, Gaz. Hopitaux, 41, 554
Remlinger J, 1905, Ann. Inst. Pasteur, 19, 625
Berger T, 1997, Lab. Invest., 76, 355
10.1097/00019052-200306000-00004 · DOI
Sharief MK, 1991, Brain, 114, 181
Bornstein MB, 1959, Trans. Am. Neurol. Assoc., 84, 165
10.1002/1531-8249(200006)47:6<694::AID-ANA2>3.0.CO;2-W · DOI
Linington C, 1988, Am. J. Pathol., 130, 443
Benczur M, 1980, Clin. Exp. Immunol., 39, 657
10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-# · DOI

Sorted by citations

Nitric Oxide and Peroxynitrite in Health and Disease
Pacher, P., Beckman, J. S., & Liaudet, L. (2007) · Physiological Reviews · doi:10.1152/physrev.00029.2006 · Cited by 6,390
Mechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580
The spectrum of neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J., & Weinshenker, B. G. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70216-8 · Cited by 2,182
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
The complex role of estrogens in inflammation
Straub, R. H. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0001 · Cited by 1,950

See all 2,149

Authors: Sospedra, M., & Martin, R.
Affiliations: National Institutes of Health (US)
Cellular Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-1400;
ORCID: Sospedra, Mireia
Venue: Annual Review of Immunology
Publisher: Annual Reviews
Published: 2005-04-01
Volume: 23
Issue: 1
Pages: 683-747
ISSN: 0732-0582 (ISSN-L)
1545-3278
DOI: 10.1146/annurev.immunol.23.021704.115707
OpenAlex: W2113291839
Cited by: 2,149
References: 362
Citations by year: 2026: 27 · 2025: 43 · 2024: 62 · 2023: 64 · 2022: 69 · 2021: 72 · 2020: 78 · 2019: 84 · 2018: 71 · 2017: 110 · 2016: 107 · 2015: 149 · 2014: 133 · 2013: 144 · 2012: 120
FWCI: 19.06
Type: journal article
Language: en
Open access: closed
Locations: Annual Review of Immunology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Keywords: multiple sclerosis, autoimmunity, CD4+ T cells, Th1 cells, Th2 cells, regulatory T cells, natural killer cells, CD8+ T cells, complement system, autoantibodies, innate immunity, viral triggers, genetic susceptibility, relapsing-remitting disease, chronic progressive disease, central nervous system, neuroimmune interactions
MeSH terms: Autoantibodies, Autoantigens, Central Nervous System, HLA Antigens, Humans, Immunity, Innate, Immunogenetics, Infections, Multiple Sclerosis, Myelin Proteins, T-Lymphocyte Subsets, Cytokines, Models, Immunological, Molecular Mimicry, Chemokines, Genomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

IMMUNOLOGY OF MULTIPLE SCLEROSIS

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks